Real-time enrollment status for this primary immune deficiency disorder clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 6:06 AM UTC
| NCT Number | NCT04232085 |
| Recruiting Status | Recruiting |
| Condition | Primary Immune Deficiency Disorder |
| Phase | PHASE2 |
| Target Enrollment | 27 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
| Last Updated on CT.gov | November 28, 2025 (Nov 28, 2025) |
As of July 19, 2026: Clinical trial NCT04232085 is currently recruiting participants. This phase2 study for primary immune deficiency disorder is actively seeking new participants at 1 location across the United States. The study is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04232085 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04232085 was last updated Nov 28, 2025 (November 28, 2025). HelloStudys verifies this status automatically.